PREDICTOM is inviting general practitioners to take part in our survey. With the aim of identifying current clinical guidelines and practice for screening, identifying and diagnosing Alzheimer's Disease and early dementia, we want to hear your views.
Photo: Svein Lunde, Helse Stavanger
Published 10 February 2025
Share this article
We are inviting general practitioners to complete this short survey. It should take around 10 minutes to complete. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.
Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation in primary care settings.
An innovative AI-powered screening gatekeeper could help transform how dementia risk is assessed. Researchers from the European PREDICTOM project have developed a risk stratification pipeline that combines established risk factors and cognitive performance data to identify people most likely to benefit from further investigation, helping target costly tests where they are needed most.
Could older adults one day participate in Alzheimer's screening without leaving home? Researchers behind the European PREDICTOM project are exploring that possibility through remote blood collection, but new findings suggest that the biggest hurdle may be getting a good blood sample in the first place.
What if Alzheimer's disease could be detected years before symptoms appear? In a newly launched nine-part video series "Predicting Dementia Before It Starts", experts from across PREDICTOM explore how advances in biomarkers, artificial intelligence, brain imaging and digital technologies, and patient involvement could enable earlier and more accurate detection of Alzheimer's disease.
